Status message

Active context: kki_bg_colors_yellow

Current Clinical Trials

The Clinical Trials Unit at Kennedy Krieger focuses on studies of many disorders, such as fragile X syndrome, tuberous sclerosis complex, and autism. 

Currently Recruiting Trials

The following studies are currently accepting new participants:

Children ages 1 - 9.99 Years of Age with MECP2 Mutation

Children with Tuberous Sclerosis Complex, Autism, and Seizures, Ages 4-15 Years

Men with Autism Spectrum Disorder, Ages 18 - 45

Tuberous Sclerosis Complex (TSC) Patients of All Ages with Visible Facial Angiofibromas

Adolescents with Major Depressive Disorder, Ages 12-17 Years

Children Receiving Psychotherapy in an Outpatient Setting and/or Have Recently Been Prescribed Sertraline, Ages 6-14

Children and Adolescents with Neurodevelopmental Disabilities and Sleep Problems, Ages 2-17.5 Years

Adolescents Diagnosed with Schizophrenia, Ages 13-17 Years

Children and Adolescents with Bipolar Depression, 10-17 Years

Children and Adolescents with Bipolar I Disorder, Ages 10-17 Years

Adults with Attention-Deficit/Hyperactivity Disorder (ADHD), Ages 18-55 Years

Adolescents Diagnosed with Schizophrenia, Ages 12-16 Years

Adolescents Who Are Diagnosed With or Have Symptoms of Schizophrenia, Ages 13-17 Years

SIrolimus Research Study for Cognitive Impairments in Sturge-Weber syndrome

Many studies for a range of diagnoses and disorders will be approved in the near future. To ensure you are among the first to learn of new studies when they open, please contact us by email or phone.

Contact Us

716 North Broadway
Baltimore, MD 21205
Phone: (443)923-3850


Read inspiring stories, news and updates about the Institute's patient care, research, special education, professional training, and community programs.